JNJ Johnson & Johnson Earnings and EPS analysis

EPS in 2026 (TTM): $8.73

Last Report Period Date: Mar 29, 2026

As of June this year, based on Johnson & Johnson's most recent financial report, the company's trailing twelve months EPS is $8.73. Johnson & Johnson's earnings per share in 2025 was reported at $11.13, marking a rise from $5.84 in 2024. Johnson & Johnson's EPS for the quarterly period ending on Mar 29, 2026 came in at $2.17.

The yearly earnings per share during 2025 was $11.13, a rise of 90.6% compared to $5.84 recorded in 2024. The quarterly earnings per share for the period ending Mar 29, 2026, was $2.17, showing a 52.5% decline compared to the same quarter last year. The trailing twelve months EPS for JNJ is $8.73 as of March 2026. Johnson & Johnson's full-year EPS for 2024 was $5.84, a 57.9% decline compared to the previous year.

In the past 12 months, Johnson & Johnson has recorded an earnings per share growth rate of -52.5% (YoY, quarterly). Across the past three years, the company had an average EPS annual growth rate of 17.7% per year. In the last five years, the company had an average annual EPS growth of 14.8%. When assessed over a ten-year period, JNJ's average EPS annual growth was 7.2%.